Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

137 recalls, newest first

Class II · Moderate risk

China-Gel White

CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.

Ongoing cGMP deviation China Gel Inc NDC 76305-301-02 D-0789-2021
Class II · Moderate risk

CHINA_GEL (Camphor 3.00%, Menthol 5.00%)

CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.

Ongoing cGMP deviation China Gel Inc NDC 76305-300-13 D-0788-2021
Class II · Moderate risk

Durisan Antimicrobial Solutions

CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the same conditions as product lots found to be contaminated.

Terminated cGMP deviation Sanit Technologies, LLC dba Durisan D-0659-2021
Class II · Moderate risk

Durisan Antimicrobial Solutions

CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the same conditions as product lots found to be contaminated.

Terminated cGMP deviation Sanit Technologies, LLC dba Durisan D-0658-2021
Class II · Moderate risk

Nortriptyline HCL capsules

cGMP deviations: The quantity of active ingredient used for the product lot was inadvertently taken from an ingredient lot from an alternate supplier before that specific lot was formally qualified for use by the manufacturing site.

Terminated cGMP deviation Direct Rx D-0300-2021

Recalls by year